Vis enkel innførsel

dc.contributor.authorLinde-Ozola, Zane
dc.contributor.authorClassen, Annika Y.
dc.contributor.authorGiske, Christian G.
dc.contributor.authorGöpel, Siri
dc.contributor.authorEliakim-Raz, Noa
dc.contributor.authorSemret, Makeda
dc.contributor.authorSimonsen, Gunnar Skov
dc.contributor.authorVehreschild, Jörg Janne
dc.contributor.authorJørgensen, Silje Bakken
dc.contributor.authorKessel, Johanna
dc.contributor.authorKleppe, Lars Kåre Selland
dc.contributor.authorOma, Dorthea Hagen
dc.contributor.authorVehreschild, Maria J.G.T.
dc.contributor.authorVilde, Aija
dc.contributor.authorDumpis, Uga
dc.date.accessioned2024-09-11T11:33:28Z
dc.date.available2024-09-11T11:33:28Z
dc.date.issued2024-03-14
dc.description.abstractBackground: Antimicrobial stewardship (AMS) programmes are established across the world to treat infections efficiently, prioritize patient safety, and reduce the emergence of antimicrobial resistance. One of the core elements of AMS programmes is guidance to support and direct physicians in making efficient, safe and optimal decisions when prescribing antibiotics. To optimize and tailor AMS, we need a better understanding of prescribing physicians’ experience with AMS guidance.<p> <p>Objectives: To explore the prescribing physicians’ user experience, needs and targeted improvements of AMS guidance in hospital settings. <p>Methods: Semi-structured interviews were conducted with 36 prescribing physicians/AMS guidance users from hospital settings in Canada, Germany, Israel, Latvia, Norway and Sweden as a part of the international PILGRIM trial. A socioecological model was applied as an overarching conceptual framework for the study. <p>Results: Research participants were seeking more AMS guidance than is currently available to them. The most important aspects and targets for improvement of AMS guidance were: (i) quality of guidelines; (ii) availability of infectious diseases specialists; and (iii) suitability of AMS guidance to department context. <p>Conclusions: Achieving prudent antibiotic use not only depends on individual and collective levels of commitment to follow AMS guidance but also on the quality, availability and suitability of the guidance itself. More substantial commitment from stakeholders is needed to allocate the required resources for delivering high-quality, available and relevant AMS guidance to make sure that the prescribers’ AMS needs are met.en_US
dc.identifier.citationLinde-Ozola, Classen, Giske, Göpel, Eliakim-Raz, Semret, Simonsen, Vehreschild, Jørgensen, Kessel, Kleppe, Oma, Vehreschild, Vilde, Dumpis. Quality, availability and suitability of antimicrobial stewardship guidance: a multinational qualitative study. JAC-Antimicrobial Resistance (JAC-AMR). 2024;6(2)en_US
dc.identifier.cristinIDFRIDAID 2263642
dc.identifier.doi10.1093/jacamr/dlae039
dc.identifier.issn2632-1823
dc.identifier.urihttps://hdl.handle.net/10037/34687
dc.language.isoengen_US
dc.publisherOxford University Pressen_US
dc.relation.journalJAC-Antimicrobial Resistance (JAC-AMR)
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2024 The Author(s)en_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0en_US
dc.rightsAttribution-NonCommercial 4.0 International (CC BY-NC 4.0)en_US
dc.titleQuality, availability and suitability of antimicrobial stewardship guidance: a multinational qualitative studyen_US
dc.type.versionpublishedVersionen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)